Equities Research Analysts’ Updated EPS Estimates for December 18th (ABM, AEP, ANGX, ARGX, BKS, BRO, COIN, CRVO, CRWD, EXOD)

Equities Research Analysts’ updated eps estimates for Thursday, December 18th:

ABM Industries (NYSE:ABM) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a $51.00 price target on the stock, down from their previous price target of $55.00.

Siebert Williams Shank assumed coverage on shares of American Electric Power (NASDAQ:AEP). Siebert Williams Shank issued a buy rating and a $137.00 target price on the stock.

Oppenheimer Holdings, Inc. assumed coverage on shares of Southport Acquisition (NYSE:ANGX). The firm issued an outperform rating and a $8.00 price target on the stock.

argenex (NASDAQ:ARGX) had its neutral rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $858.00 price target on the stock, down from their previous price target of $924.00.

Beeks Financial Cloud Group (LON:BKS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 335 target price on the stock.

JPMorgan Chase & Co. started coverage on shares of Brown & Brown (NYSE:BRO). JPMorgan Chase & Co. issued a neutral rating and a $91.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $420.00 price target on the stock.

CervoMed (NASDAQ:CRVO) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $25.00 target price on the stock.

CrowdStrike (NASDAQ:CRWD) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $590.00 price target on the stock.

Exodus Movement (NYSEAMERICAN:EXOD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $25.00 price target on the stock.

4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reaffirmed by analysts at Chardan Capital. The firm currently has a $26.00 price target on the stock.

FRP Advisory Group (LON:FRP) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 220 price target on the stock.

Hut 8 (NASDAQ:HUT) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 target price on the stock.

Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $65.00 price target on the stock.

Kennedy-Wilson (NYSE:KW) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $11.00 target price on the stock.

Lennar (NYSE:LEN) had its underperform rating reissued by analysts at Bank of America Corporation. They currently have a $95.00 target price on the stock, down from their previous target price of $125.00.

Wells Fargo & Company began coverage on shares of Southwest Airlines (NYSE:LUV). Wells Fargo & Company issued an equal weight rating and a $45.00 target price on the stock.

MediciNova (NASDAQ:MNOV) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $9.00 price target on the stock.

Mereo BioPharma Group (NASDAQ:MREO) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $6.00 target price on the stock.

Realty Income (NYSE:O) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $61.00 price target on the stock.

PACS Group (NYSE:PACS) had its buy rating reissued by analysts at UBS Group AG. UBS Group AG currently has a $42.00 price target on the stock, down from their previous price target of $50.00.

Public Storage (NYSE:PSA) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $301.00 price target on the stock, down from their previous price target of $316.00.

Quantum Computing (NASDAQ:QUBT) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $15.00 price target on the stock.

TD Cowen began coverage on shares of Rapt Therapeutics (NASDAQ:RAPT). TD Cowen issued a buy rating on the stock.

Regency Centers (NASDAQ:REG) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $76.00 price target on the stock, down from their previous price target of $81.00.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $12.00 target price on the stock.

Bank of America Corporation initiated coverage on shares of SiteOne Landscape Supply (NYSE:SITE). Bank of America Corporation issued a buy rating and a $147.00 price target on the stock.

Noble Financial initiated coverage on shares of Summit Midstream Partners (NYSE:SMC). Noble Financial issued an outperform rating and a $47.00 target price on the stock.

Strategic Education (NASDAQ:STRA) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $105.00 price target on the stock.

United Dominion Realty Trust (NYSE:UDR) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $40.00 target price on the stock, down from their previous target price of $42.00.

Canaccord Genuity Group Inc. initiated coverage on shares of Veru (NASDAQ:VERU). The firm issued a buy rating and a $25.00 target price on the stock.

Vital Farms (NASDAQ:VITL) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $45.00 target price on the stock.

Lake Street Capital began coverage on shares of Vishay Precision Group (NYSE:VPG). They issued a buy rating and a $44.00 price target on the stock.

The Glimpse Group (NASDAQ:VRAR) had its buy rating reaffirmed by analysts at Westpark Capital. The firm currently has a $2.62 target price on the stock.

Welltower (NYSE:WELL) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $205.00 price target on the stock.

Expro Group (NYSE:XPRO) was downgraded by analysts at Piper Sandler from a neutral rating to an underweight rating. The firm currently has $13.00 price target on the stock.